Acupuncture to Improve Comfort of Children on a Ventilator in the Intensive Care Unit

August 11, 2020 updated by: Lin Di Gennaro, Seattle Children's Hospital

Safety, Feasibility & Effectiveness of Acupuncture as an Adjunct to Pharmacologic Treatment for Sedation and Analgesia in Mechanically Ventilated PICU Patients - A Pilot Study

The purpose of this study is to determine whether acupuncture is effective at improving comfort in children on a ventilator in the intensive care unit. Our hypothesis is that the patients receiving acupuncture will require less medications to keep them comfortable than those who receive sham or fake acupuncture.

Study Overview

Status

Completed

Conditions

Detailed Description

Rationale: Use of narcotics and benzodiazepines is common in the pediatric intensive care unit (PICU) to alleviate pain and anxiety, especially for patients who are mechanically ventilated. Pain control and sedation decrease oxygen consumption, facilitate mechanical ventilation, ensure patient safety and help patients tolerate nursing care. However, these medications can also have negative consequences. Patients receiving greater amounts of pharmacologic sedation in the intensive care unit (ICU) have longer duration of mechanical ventilation and ICU length of stay. In fact, daily interruption of sedation shortens duration of mechanical ventilation and ICU length of stay. Sedatives have also been associated with development of delirium in ICU patients and linked to delusional and disturbing memories and post-traumatic stress disorder (PTSD) after recovery from critical illness. Benzodiazepines and opiates are associated with abnormal sleep architecture. Furthermore, patients experience tolerance, physical dependency and withdrawal from these agents. Lastly, there is evidence that sedatives, anesthetics and opiates are associated with neurotoxicity in animal studies leading to growing concern about the potential effects of these agents on the developing brains of children.

Novel Approach: In light of these negative aspects of pharmacologic sedation, we are looking for alternative ways to provide comfort to critically ill children in the PICU. Acupuncture has been found to be effective in reducing anxiety, acute pain, procedural pain, post-operative pain, chronic pain, headache, infant colic, and has been found to reduce anesthetic requirement during surgery.

Study Plan: We plan to randomize patients 6 months - 17 yrs old who are receiving mechanical ventilation in the PICU to either acupuncture or sham acupuncture as an adjunct to standard of care pharmacologic sedation as prescribed by the PICU medical team caring for the patients. Our hypothesis is that those patients receiving acupuncture will require less medications to keep them comfortable. Our study is powered (80%) to detect a 33% decrease in pharmacologic sedation/analgesia.

Study Type

Interventional

Enrollment (Actual)

17

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Washington
      • Seattle, Washington, United States, 98105
        • Seattle Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 months to 17 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age ≥6 months to <18 years
  • intubated and mechanically ventilated
  • patient requires pharmacologic sedation/analgesia to tolerate mechanical ventilation
  • ≤72 hours of mechanical ventilation at time of enrollment with anticipated need of mechanical ventilation for at least ≥48 hours more (in order to be able to receive at least one acupuncture session)
  • approval of treating physician

Exclusion Criteria:

  • underlying neurologic condition that could impact sedation/analgesia needs
  • coagulopathy (inr ≥ 1.8) or history of spontaneous bruising
  • thrombocytopenia (platelets <20,000 that has not been treated with a platelet transfusion)
  • hemodynamic instability (on continuous infusion of vasopressor or inotrope)
  • sepsis or bacteremia on antibiotic therapy <24 hours
  • severe generalized skin disorder (e.g., epidermolysis bullosa, Stevens-Johnson)
  • ward of state
  • being treated with therapeutic level of systemic anticoagulation (e.g., heparin with unfractionated heparin activity level ≥0.3, enoxaparin with low molecular weight heparin activity level ≥0.5, warfarin with inr ≥1.8)
  • immunosuppressed (on chemotherapy {e.g., daunorubicin, vincristine}, immunosuppressive medications {e.g., sirolimus, tacrolimus, cyclosporine, mycophenolate mofetil, high dose steroids >4mg/kg/day}, or immunosuppressive biologics {e.g., thymoglobulin, etanercept, infliximab, adalimumab, rituximab})

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: QUADRUPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Acupuncture
Acupuncture treatment three times per week for up to two weeks.
Patients randomized to active treatment will receive acupuncture treatment with press needles (small acupuncture needles manufactured with attached bandage that makes the needle flush with skin) at sites GV 24.5 or GV20, Ht 7 or Ht 3, Ki 3, Lr 3, LI 4 or LI 11, Lu 7 or Lu 5, Sp6, ST 36, using up to 15 points per patient three days per week for the duration of mechanical ventilation (maximum of 14 calendar days from the time of the first acupuncture treatment). We will also apply a seed magnet at ear shen men position for 4 hours on treatment days.
Other Names:
  • Pyonex Singles, Seirin® (0.20 mm diameter, 1.5 mm long)
SHAM_COMPARATOR: Sham Acupuncture
Sham acupuncture three times per week for up to two weeks
Patients randomized to sham treatment will receive sham acupuncture with similarly appearing bandages placed without press needles attached at sites GV 24.5 or GV20, Ht 7 or Ht 3, Ki 3, Lr 3, LI 4 or LI 11, Lu 7 or Lu 5, Sp6, ST 36, using up to 15 points per patient three days per week for the duration of mechanical ventilation (maximum of 14 calendar days from the time of the first acupuncture treatment). We will also apply a similarly appearing bandage without seed magnet underneath at ear shen men position for 4 hours on treatment days.
Other Names:
  • Pyonex Singles, Seirin® (bandage only, no needle)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Average Daily Dexmedetomidine mcg/kg/Day
Time Frame: from time of first acupuncture/sham treatment till time of extubation
Measured total amount of dexmedetomidine received from time of first acupuncture or sham treatment to extubation, normalized per weight and time on study (1st study treatment to extubation).
from time of first acupuncture/sham treatment till time of extubation
Average Daily Morphine Equivalents (mg/kg/Day)
Time Frame: from time of first acupuncture/sham treatment till time of extubation
Measured total amount of morphine equivalent received from time of first acupuncture or sham treatment to extubation, normalized per weight and time on study (1st study treatment to extubation).
from time of first acupuncture/sham treatment till time of extubation
Average Daily Midazolam Equivalents (mg/kg/Day)
Time Frame: from time of first acupuncture/sham treatment till time of extubation
Measured total amount of midazolam equivalent received from time of first acupuncture or sham treatment to extubation, normalized per weight and time on study (1st study treatment to extubation).
from time of first acupuncture/sham treatment till time of extubation
Average Daily Sedation Score
Time Frame: from time of first acupuncture/sham treatment till time of extubation
To capture a global view of sedation and account for the combination of medications received, we also calculated an average daily 'sedation score' normalized for weight from the time of first treatment through extubation. The sedation score is a summary measure of sedative and analgesic exposure for mechanically ventilated children in the ICU. This score incorporates opioids, benzodiazepines, barbiturates, chloral hydrate, propofol, and antihistamines. Morphine and midazolam equivalents of 0.1 mg/kg, pentobarbital 2 mg/kg, chloral hydrate 50 mg/kg, any propofol use, and any phenobarbitol use are each allocated one point, while any antihistamine use receives a score of 0.5 (Randolph 2002, Curley 2005). We modified this score to include dexmedetomidine, assigning 1 point for 1 μg/kg of dexmedetomidine. The minimum value possible is zero, and there is no pre-defined maximum value. A higher score indicates higher dose of sedation medications (normalized by weight).
from time of first acupuncture/sham treatment till time of extubation

Secondary Outcome Measures

Outcome Measure
Time Frame
Number of Participants With Skin Ulceration at Acupuncture/Sham Sites
Time Frame: From time of first treatment through 2 to 3 days after last treatment.
From time of first treatment through 2 to 3 days after last treatment.
Number of Participants With Hematoma at Acupuncture/Sham Sites
Time Frame: From time of first treatment through 2 to 3 days after last treatment.
From time of first treatment through 2 to 3 days after last treatment.
Number of Participants With Cellulitis at Acupuncture/Sham Sites
Time Frame: From time of first treatment through 2 to 3 days after last treatment.
From time of first treatment through 2 to 3 days after last treatment.
Number of Participants Who Are Diagnosed With Bacteremia During the Study
Time Frame: From time of first treatment through 2 to 3 days after last treatment.
From time of first treatment through 2 to 3 days after last treatment.
Number of Participants Who Are Diagnosed With Septic Shock During the Study
Time Frame: From time of first treatment through 2 to 3 days after last treatment.
From time of first treatment through 2 to 3 days after last treatment.
Death While Enrolled in Study
Time Frame: From time of first treatment through 2 to 3 days after last treatment.
From time of first treatment through 2 to 3 days after last treatment.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jane L Di Gennaro, MD, MS, Seattle Children's Hopsital
  • Principal Investigator: Anne Lynn, MD, Seattle Children's Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2013

Primary Completion (ACTUAL)

June 1, 2016

Study Completion (ACTUAL)

June 1, 2016

Study Registration Dates

First Submitted

May 2, 2013

First Submitted That Met QC Criteria

May 2, 2013

First Posted (ESTIMATE)

May 7, 2013

Study Record Updates

Last Update Posted (ACTUAL)

August 13, 2020

Last Update Submitted That Met QC Criteria

August 11, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Agitation

Clinical Trials on acupuncture

Subscribe